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Evaluation studies of outcomes used in clinical research and their consistency are appear-
ing more frequently in the literature, as a key part of the core outcome set (COS) develop-
ment. Current guidance suggests such evaluation studies should use systematic review
methodology as their default. We aimed to examine the methods used. We searched the
Core Outcome Measures in Effectiveness Trials (COMET) database (up to May 2019) sup-
plementing it with additional resources. We included evaluation studies of outcome consis-
tency in clinical studies across health subjects and used a subset of A MeaSurement Tool
to Assess systematic Reviews (AMSTAR) 2 (items 1–9) to assess their methods. Of 93
included evaluation studies of outcome consistency (90 full reports, three summaries), 91%
(85/93) reported performing literature searches in at least one bibliographic database, and
79% (73/93) was labelled as a “systematic review”. The evaluations varied in terms of satis-
fying AMSTAR 2 criteria, such that 81/93 (87%) had implemented PICO in the research
question, whereas only 5/93 (6%) had included the exclusions list. None of the evaluation
studies explained how inconsistency of outcomes was detected, however, 80/90 (88%) con-
cluded inconsistency in individual outcomes (66%, 55/90) or outcome domains (20%, 18/
90). Methods used in evaluation studies of outcome consistency in clinical studies differed
considerably. Despite frequent being labelled as a “systematic review”, adoption of system-
atic review methodology is selective. While the impact on COS development is unknown,
authors of these studies should refrain from labelling them as “systematic review” and
focus on ensuring that the methods used to generate the different outcomes and outcome
domains are reported transparently.
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Introduction
Inconsistency (or heterogeneity) of outcomes measured in clinical studies is a widely recog-
nised problem hindering evidence synthesis. [1–5] Core outcome sets (COS), defined as a min-
imum set of outcomes to be reported from all intervention trials sharing a common research
objective, have been advocated as a solution to this problem. [6, 7] A growing number of stud-
ies aiming to develop a COS for conditions across a range of health areas [8, 9], is accompanied
by reviews aiming to assess the consistency of outcomes in a formal way. [10–12]
Prior to the release of the Core Outcome Measures in Effectiveness Trials (COMET) hand-
book [13], guidance on a COS-related methodology was mostly focused on aspects of the
consensus process. [14] Review of past research appears in the handbook in the context of
assessing a need for a COS—described as an optional step—and informing a list of outcomes
for a consensus process. The guidance on the conduct of this type of assessments is succinct
and suggests the adoption of a systematic review approach. [13–15]
The method of systematically reviewing literature was introduced as a comprehensive way
of summarising the evidence for the purpose of medical decision-making and identification of
unanswered research questions. [16–19] The methodological rigour required for systematic
review, which intends to minimise biases and provide a robust estimation of an underlying
treatment effect, [16] requires considerable time and resources. [19, 20] The benefits of apply-
ing the same approach to the assessment of outcome consistency or generating a long list of
outcomes for Delphi survey is unclear. [21]
Therefore, we set out to assess the methods adopted in evaluation studies of outcome con-
sistency published to-date and examine their adoption of systematic review methods. Further-
more, we checked if identified evaluation studies were part of a COS project, examined
methods specific to determining outcome consistency, such as type of collected outcomes,
methods of their identification, and how authors assessed and presented outcome consistency
or need for a COS.
Materials and methods
Our work was guided by a prospectively developed protocol registered with PROSPERO
(CRD42018100481).
Identification of relevant studies
We included full texts of evaluation studies of outcome consistency in clinical studies on any
health condition. We recognise that, even though, the COMET handbook refers to these type
of evaluations as “systematic reviews” there is no consensus on the type of study design for this
type of evaluation studies. Aiming to gain a thorough overview of the practices in this area and
acknowledging lack of consensus regarding the study design, we decided to include any study
design regardless of the design labelling. We searched the COMET database from its inception
to June 2018; the search was updated in May 2019. [8] The COMET database is an annually
updated repository of the international COS literature based on the systematic searches run in
MEDLINE, SCOPUS, and Cochrane Methodology Register. [9] The search was supplemented
with the resource of the Core Outcomes in Women’s and Newborn Health (CROWN) initia-
tive [10, 22] and check of references of the included studies. Systematic reviews of treatment
effects with a secondary conclusion regarding outcome reporting, reviews of outcomes from
non-clinical settings (registers, audits, population databases), COS protocols and reports men-
tioning outcome assessment but not describing them and studies focusing on a very narrow
group of outcomes (e.g. only pain-related outcomes) were excluded.
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Data collection
All data were collected using a prospectively developed and piloted data collection form (S1
Text) and subsequently amalgamated into a master file in MS Excel. We collected information
on publication year, medical speciality, evaluation’s aims, scope (number of included studies
and their type), whether the design was labelled as a “systematic review” and was it a part of a
COS project (based on study acronym or the information provided in the publication). In
order to examine the adoption of systematic review methodology, all evaluation studies
(regardless of declared study design) were assessed against a tailored subset of A MeaSurement
Tool to Assess systematic Reviews (AMSTAR) 2 items [23] we felt were relevant (S1 Table).
AMSTAR was designed as a practical critical appraisal instrument enabling rapid and repro-
ducible quality assessments of systematic reviews. In our work, we used items covering the
development of a study protocol (items 1–3), identification and selection of eligible studies
(items 4–5), data collection (item 6), reporting (item 7–8) and study quality assessment (item
9). The remaining items (10 to 16) were not assessed as we felt they were not applicable to eval-
uation studies of outcome consistency (e.g. study funding, aspects of meta-analysis, publica-
tion bias, etc.).
Information collected on the outcome-specific methods covered following elements: type of
outcome (primary/secondary); a way of determining outcome type (clearly specified as pri-
mary or secondary, used in power calculation, etc.); approach to outcome extraction (any out-
come reported in the publication or just those from the methods or results sections); use of
any tool to assess the quality of outcome description; outcome unit as reported by the publica-
tion (individual outcomes or outcome groups); presentation of the findings (text, table,
graphic format); and the conclusions. The conclusion section was examined for presence of
any statement regarding inconsistency of assessed outcomes (heterogeneity, variation, etc.)
or a need for a COS. Where detection of outcome inconsistency was concluded, we examined
the methods and protocol of the evaluation, if available, for any description of how outcome
inconsistency was defined. Where the need for a COS development was concluded, we looked
for arguments given in the publications to support this conclusion. Double data extraction
(AA, ROR or ER) and assessment of the subset of AMSTAR 2 items were performed on half of
the included evaluations. Remaining evaluations were extracted and assessed by a single senior
reviewer (ER). All discrepancies and statements supporting final judgements were recorded in
the final Excel dataset.
Strategy for data synthesis
Extracted data were cross-tabulated and presented either as frequencies or as median with
corresponding interquartile range (IQR). When examining detection of outcome consistency,
we assessed only studies with a full description of outcome assessment. Fisher’s exact test was
used to explore the potential difference between the evaluation studies labelled as “systematic
review” and those that were not labelled as such. All descriptive summaries and graphs were
computed with Excel software (MS Office 2016). The comparison of two groups—labelled and
not labelled as “systematic review” was performed using Stata version 15.1.
Results
Study selection process and description of included studies
Out of 237 records assessed, 93 evaluation studies met the inclusion criteria—90 full reports
and three summaries of outcome assessment in the final report of the COS project (S1 Fig).
The main reason for records exclusion was that the objective was outside of this work’s scope,
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e.g. assessment of measurements, instruments, scales or definitions (S2 Table). Included evalu-
ation studies were mainly published between 2014 and 2019 (Fig 1), included a median of 68
studies (Table 1) and covered topics across 24 medical areas (S3 Table). Around two-thirds
(63/93) of the evaluation studies set out to assess outcome consistency or need for a COS in
their objectives and around half (48/93) could have been linked to a COS project. Almost 80%
(73/93) described their design as a “systematic review” (Table 1).
Systematic review methodology in evaluations of outcome consistency
In most evaluation studies, we could identify a structured research question (87%, 81/93). Half
of them declared having a protocol (50%, 46/93), of which 46% had been prospectively regis-
tered with PROSPERO (21/46) (S4 Table). In many, study identification (66%, 61/93) or data
extraction (50%, 49/93) were carried out by two researchers (in duplicate). Authors rarely pro-
vided an exclusions list (5%, 5/93), a rationale behind the inclusion of specific study design
(20%, 19/93), or performed quality assessment of included clinical studies (28%, 26/93)
(Table 2). Even though in 91% of the evaluation studies (85/93) the literature search was per-
formed in at least one bibliographical database (median of three databases per review) (S3
Table), we were able to classify only 33% (28/85) of them as comprehensive, as per AMSTAR 2
criteria, based on provided search details. The difference between evaluation studies labelled
and not labelled as “systematic review” was statistically significant for the proportion of evalua-
tion studies where study selection or data extraction were performed by at least two research-
ers, or the authors provided adequate description of included clinical studies (Table 2).
Methods used to identify outcomes and their consistency
The number of identified outcomes was reported in 93% (86/93) of the evaluation studies
with 40% (37/93) specifying from which section of the trial publication, the outcomes were
Fig 1. Number of evaluation studies of outcome consistency in clinical studies over time.
https://doi.org/10.1371/journal.pone.0235485.g001
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extracted. In two-thirds (63/93) of the evaluation studies, the authors made the distinction
between primary and secondary outcomes, of which many also described how they ascertained
whether the outcome was primary or not (41/63) (Table 3). Over half of the evaluation studies
(55/90) looked at individual outcomes, 20% (18/90) assessed outcome domains (i.e. groups
of individual outcomes referring to the same phenomena) and the remainder (19%, 17/90)
applied both approaches (Table 3). Outcomes were frequently (90%, 81/90) presented in a tab-
ulated format, and around one fifth (21%, 19/90) used a matrix to present outcome distribu-
tion (Fig 2).
We found statements on the inconsistency of outcomes in conclusions of 88% (80/90) of
the assessed evaluation studies. None provided a description of how this inconsistency was
defined or detected. The need for a COS was declared in 82% (74/90) and frequently justified
by the encountered inconsistency of assessed outcomes (76%, 68/90) (Table 3).
Discussion
The methods adopted in the evaluation studies of outcome consistency were variable, and
none implemented all nine of the methodological expectations of systematic reviews as
Table 1. Characteristics of included evaluation studies of outcome consistency.
Characteristic N Descriptive
Number of clinical studies per evaluation (median, Q1-3) 93 68 (34–133)
Distinction between primary and subsequent publications, n (%) 93 30 (32)
Objective(s) of evaluation study 93
To assess a need for COS or consistency in outcome selection, n (%) 63 (67)
To identify outcomes for Delphi survey in COS development, n (%) 18 (47)
To explore outcome-reporting, n (%) 13 (14)
Evaluation study linked with a core outcome set project 93 48 (51)
Evaluation study labelled as a “systematic review” 93
Yes, n (%) 73 (79)
No, n (%) 20 (21)
When the evaluation study was not labelled as “systematic review”, what other term was used
to describe the design:
20
“Literature review” 11 (55)
“Review of outcomes” 2 (10)
“Analysis of outcome reporting” 1 (5)
“Electronic database search” 1 (5)
“Survey” 1 (5)
“Outcome mapping” 1 (5)
“Systematic exploration” 1 (5)
“Analysis of studies 1 (5)
“Scoping review” 1 (5)
Types of research included in the evaluation studies of outcome consistency
Primary research
Full scale clinical study (e.g. RCTs, cohort studies), n (%) 93 59 (63)
Feasibility or pilot study, n (%) 93 8 (9)
Secondary research (literature review) 93 27 (29)
When the literature review was included, the purpose was to:
Identify outcomes, n (%) 27 10 (37)
Identify clinical studies for outcome assessment, n (%) 27 15 (56)
https://doi.org/10.1371/journal.pone.0235485.t001
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Table 2. Systematic review methods as specified in the subset of AMSTAR 2 items in evaluation studies of outcome consistency.








1 Did the research questions and inclusion criteria include the components of
PICO?
Overall 81 (87) 9 (10) 3 (3) 0
Labelled as
“Syst rev”
64 (88) 8 (11) 1 (1) 0.129
Not labelled as
“Syst rev”
17 (85) 1 (5) 2 (10)
2 Did the report contain an explicit statement that the methods were established
prior to the conduct of the review and did the report justify any significant
deviations from the protocol?
Overall 46 (50) 5 (5) 42 (45) 0
Labelled as
“Syst rev”
42 (58) 4 (5) 27 (37) 0.06
Not labelled as
“Syst rev”
4 (20) 1 (5) 15 (75)
3 Did the authors explain their selection of the study designs for inclusion? Overall 19 (20) 0 74 (80) 0
Labelled as
“Syst rev”
17 (23) 0 56 (77) 0.346
Not labelled as
“Syst rev”
2 (10) 0 18 (90)
4 Did the authors use a comprehensive literature search strategy? Overall 28 (33) 4 (5) 53 (62) 8
Labelled as
“Syst rev”
23 (32) 3 (4) 43 (59) 0.200
Not labelled as
“Syst rev”
5 (25) 1 (5) 10 (50)
5 Did the authors perform study selection in duplicate? Overall 61 (66) 21 (23) 10 (11) 1
Labelled as
“Syst rev”
56 (77) 11 (15) 5 (7) <0.001
Not labelled as
“Syst rev”
5 (25) 10 (50) 5 (25)
6 Did the authors perform data extraction in duplicate? Overall 49 (53) 32 (34) 12 (13) 0
Labelled as
“Syst rev”
45 (62) 21 (29) 7 (10) 0.002
Not labelled as
“Syst rev”
4 (20) 11 (55) 5 (25)
7 Did the authors provide a list of excluded studies and justify the exclusions? Overall 5 (6) 0 84 (94) 4
Labelled as
“Syst rev”
4 (5) 0 66 (90) 1.00
Not labelled as
“Syst rev”
1 (5) 0 18 (90)
8 Did the authors describe the included studies in adequate detail? Overall 37 (42) 2 (2) 50 (56) 4
Labelled as
“Syst rev”
35 (48) 2 (3) 33 (45) 0.006
Not labelled as
“Syst rev”
2 (10) 0 17 (85)
9 Did the authors assess the quality of included studies? Overall 26 (29) 0 64 (71) 3
Labelled as
“Syst rev”
22 (30) 0 49 (67) 0.474
Not labelled as
“Syst rev”
4 (20) 0 15 (75)
N/A, not applicable; Syst rev, systematic review;
�Percentages calculated using as denominator number without evaluation studies in N/A category;
https://doi.org/10.1371/journal.pone.0235485.t002
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described in AMSTAR 2. The proportion of evaluation studies labelled as a “systematic review”
and those that were not differed in three AMSTAR 2 items (duplicate identification of eligible
studies, duplicate data extraction, and description of included clinical studies in sufficient
detail). Most of the evaluations concluded that there was evidence of inconsistency in the out-
comes used across clinical studies. Although none described how this inconsistency was deter-
mined, it was frequently cited to justify the need for COS development.
Table 3. Methods used to identify and assess outcomes in evaluation studies of outcome consistency.
Characteristic n/N� (%)
Evaluation studies reporting the number of identified outcomes (individual or domains) 86/90 (96)
Number of extracted outcomes (individual or domains) per review (median, Q1 to 3) 80 (43 to
158)
Distinction between primary and secondary outcomes 63/93 (68)
When the distinction between the type of outcome(s) was made:
The primary outcome(s) was clearly specified as a primary 27/63 (43)
The primary outcome(s) was clearly specified as a primary or used in the power calculation 11/63 (17)
The primary outcome(s) was identified using other measures (e.g. outcome mentioned in the trial
title, first reported)
3/63 (5)
There were no details of how the primary outcome(s) was identified 22/63 (35)
Approach to outcome extraction
Outcomes mentioned anywhere in the report 22/93 (24)
Outcomes mentioned only in methods 11/93 (12)
Outcomes mentioned only in results 4/93 (4)
Not specified or unclear 56/93 (60)
Quality assessment of outcome reporting 17/93 (18)
Outcomes presented
Only individually 55/90 (61)
Only grouped into domains�� 18/90 (20)
In both ways (individually and grouped in domains) 17/90 (19)
Presentation of extracted outcomes
Table of outcomes (individual or domains) with the number of studies 81/90 (90)
Matrix (outcomes per study) 20/90 (22)
Other graphic formats (e.g. bar chart, Venn diagram, Spiral graph) 41/90 (46)
Conclusion regarding outcome consistency
Detection of inconsistency in outcome choice 80/90 (88)
Detection of a need for COS 74/90 (82)
Due to identified inconsistency in outcome choice 68/90 (76)
Due to other reasons than inconsistency in outcome choice 6/90 (7)
Conclusions of evaluations
Wide range of identified outcomes (individual or domains) 55/90 (61)
Difference in how, rather than which, the outcome was measured 52/90 (58)
Infrequent reporting of outcomes relevant to patient care 37/90 (41)
Impact of inconsistency in outcome choice on evidence synthesis 13/90 (14)
Difference in when the outcomes were measured 12/90 (13)
� Three reports (3/93) of full core outcome sets were excluded from some assessments (N = 90) as they focused only
on providing a list of identified outcomes without reporting more details (see S3 Table)
�� Outcome domain, constructs used to broadly classify individual outcomes referring to the same phenomena into a
group
https://doi.org/10.1371/journal.pone.0235485.t003
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Our work provides the first extensive evaluation of methods used in evaluation studies of
outcome consistency in clinical studies to date. It was guided by a prospectively developed pro-
tocol using broad inclusion criteria to facilitate identification of a representative sample of the
studies of outcomes. Despite the benefits of publication of methodological study protocols are
yet to be determined [23], their development can enhance the study’s reproducibility. [24]
Our methods heavily borrow from a systematic review process; however, our work is not a sys-
tematic review and should not be judged like one. For example, we did not set out to run an
extensive search across numerous databases instead of relying on the COMET database and
supplemented its results with the resources of the CROWN initiative. [25] Use of such a spe-
cific source of studies might be perceived as a limiting factor leading to the omission of some
relevant publications. On the other hand, the COMET database is updated periodically, using
extensive search strategy, for COS-related literature. [8] In this exploratory study of published
literature, we aimed to obtain a pragmatic sample of studies using relevant sources. We did
not search the international prospective register of systematic reviews (PROSPERO) [26], due
to lack of specific indexing of this type of evaluation studies resulting in the inability to retrieve
relevant records. As only less than a quarter of the included evaluation studies registered their
Fig 2. Matrix of outcomes—example.
https://doi.org/10.1371/journal.pone.0235485.g002
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protocols with PROSPERO, we believe that omission of this source did not have a substantial
impact on our work.
AMSTAR 2 was primarily developed to examine the robustness of systematic reviews of
healthcare interventions. [27] Thus, the use of a subset of its items in this work might be con-
tested. We decided to use AMSTAR 2 for two reasons, the COMET handbook reference to the
evaluation studies of outcome consistency as “systematic reviews”, and previous evaluation of
COS-related literature in the area of women’s health. [10] We selected the most relevant and
applicable across a broader spectrum of study designs AMSTAR 2 items (S1 Table). Their
application to all included evaluation studies allowed us to have a uniform comparison of the
methods regardless of how they were labelled. Even though, a quarter of the evaluations in
our sample did not self-identified as a “systematic review”, the proportion of those satisfying
AMSTAR 2 criteria labelled and not labelled as “systematic review” did not differ in six out of
nine evaluated items.
Publication of the COMET Handbook [13] and related resources [14, 15, 28] increased
access to guidance on robust methods for COS development. However, advice on methodol-
ogy to evaluate outcomes to inform COS development is currently limited to a suggestion of
adopting systematic review methodology. [13, 14] Evaluation studies of outcome consistency
are a relatively new phenomenon with only a handful of this type of studies published before
2010 (Fig 1). Thus, the observed differences in the adopted methods probably arise from this
limited guidance. In recent years, there has been a growing body of literature focusing on the
methodological aspects of medical research [29]. The methodology of methods-orientated
studies is inherently heterogeneous [29] and may involve features of a systematic review [21].
Nevertheless, the authors should refrain from labelling their work as “systematic review” when
this is not the case [21], ensuring that their methodological explorations are guided by a robust
methodology.
A well-executed systematic review is a resource-intensive and meticulous synthesis of avail-
able evidence. [16] Application of systematic review methods to assess outcome consistency
raises a question over a value of applying such workload intense methodology—mainly in the
form of researchers’ time. Evaluation studies included in this work frequently aimed to assess
the need for a COS and, simultaneously, collect outcomes to inform a subsequent Delphi
survey. Delphi process tends to comprise multiple sources of information for generating the
initial list of outcomes with a literature assessment of outcome being only one of them. Delphi
enables involved stakeholders to propose relevant outcomes not yet captured on the list. [30]
Thus, the rationale for conducting a systematic review to inform this process is unclear. Given
that the impact of the methods of discussed evaluation studies of outcome consistency on the
COS development process is unknown; authors should consider whether a systematic review
approach is warranted.
None of the assessed evaluation studies specified how inconsistency of outcomes was
detected; yet, the majority claimed in their conclusion to have identified such inconsistency.
This finding highlights the need for more transparency in the design and reporting of these type
of evaluations and is consistent with the conclusion of a recent COS literature. In their work,
Young et al. examined number of reported outcomes, their definitions, timing, and approach to
their grouping in 132 studies (development papers, protocols, and reviews) and found meaning-
ful differences. [31] Based on their findings, they proposed a definition for a unique outcome
and inconsistency of outcomes referred to in their work as outcome reporting heterogeneity
(ORH). [31] The proposed definition brings attention to a difference between the number of
identified outcomes (however defined) and their overlap between the clinical studies.
The methods of evaluation studies of outcome consistency published to date differ in their
approach to the identification of eligible studies and their outcomes. Although frequently
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labelled as “systematic review”, their methods seldom satisfied the standards set for systematic
reviews in the aspects of the process described by the first nine items of AMSTAR 2. In the
absence of evidence of a benefit of adopting the systematic review approach in this context, we
encourage researchers embarking on these type of project to follow general principles of sys-
tematic review practice. This should include the development of a research protocol with a
clear description of intended methods and how researchers plan to determine if the main
objective has been achieved and transparent reporting of the study. [32, 33] However, we dis-
courage labelling this type of evaluation, as a “systematic review”. Instead, we propose the use
of terms such as “evaluation of outcomes” or “outcome mapping.” Alternatively, authors may
choose to use an established approach, such as “scoping review” and adopt the appropriate
methodological and reporting standards [34, 35].
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